RLYB: Rallybio Corporation Stock

by  •  • Comments Off on RLYB: Rallybio Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 12.51
Enterprise Value ($M) -2.27
Book Value ($M) 54.07
Book Value / Share 1.30
Price / Book 0.23
NCAV ($M) 53.47
NCAV / Share 1.28
Price / NCAV 0.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.89
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.54

Liquidity (mrq)
Quick Ratio 14.68
Current Ratio 14.68

Balance Sheet (mrq) ($M)
Current Assets 57.38
Assets 57.98
Liabilities 3.91
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.64
Operating Income -60.50
Net Income -57.77

Cash Flow Statement (mra) ($M)
Cash From Operations -49.28
Cash from Investing 33.49
Cash from Financing 5.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc 4.30 -23.70
07-30 13G Johnson & Johnson 8.80
07-30 13G/A Canaan XI L.P. 4.97 -0.07

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 14,358 71,239 20.15
2025-05-07 4,232 42,881 9.87
2025-05-06 13,771 113,377 12.15
2025-05-05 20,059 89,459 22.42

(click for more detail)

Similar Companies
RGNX – REGENXBIO Inc. RIGL – Rigel Pharmaceuticals, Inc.
RLMD – Relmada Therapeutics, Inc. ROIV – Roivant Sciences Ltd.
RPRX – Royalty Pharma plc


Financial data and stock pages provided by
Fintel.io